Deadline: 30 August 2024
The Medicines for Malaria Venture invites proposals from African scientists to advance malaria drug development.
The proposals funded as part of this call will have a project start date of 1 January 2025, once a legal agreement is reached between MMV and the relevant parties.
Focus Areas
- Compounds with confirmed activity on any antimalarial lifecycle stage
- Novel molecules with confirmed activity (EC50 < 10uM) and a medicinal chemistry plan that tackles any known or anticipated liability. In line with MMV strategic goals, priority will be given to compounds with potential for optimization as drugs for chemoprevention with a human half-life >120h.
- Assay development and screening
- Assay development and screening to support discovery or development of novel antimalarials.
- Computer-aided drug discovery
- Use of computational approaches (cheminformatic and/or bioinformatic) to discover new molecules with predicted antimalarial activity or new antimalarial drug targets.
Eligibility Criteria
- To be eligible for consideration for funding as part of this call, MMV welcomes proposals only from African scientists.
For more information, visit MMV.
